Cargando…

Shared decision-making in advanced kidney disease: a scoping review protocol

INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Engels, Noel, de Graav, Gretchen, van der Nat, Paul, van den Dorpel, Marinus, Bos, Willem Jan, Stiggelbout, Anne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050317/
https://www.ncbi.nlm.nih.gov/pubmed/32111615
http://dx.doi.org/10.1136/bmjopen-2019-034142
_version_ 1783502603255021568
author Engels, Noel
de Graav, Gretchen
van der Nat, Paul
van den Dorpel, Marinus
Bos, Willem Jan
Stiggelbout, Anne M
author_facet Engels, Noel
de Graav, Gretchen
van der Nat, Paul
van den Dorpel, Marinus
Bos, Willem Jan
Stiggelbout, Anne M
author_sort Engels, Noel
collection PubMed
description INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality decisions that align with their values and preferences. However, systematic reviews or scoping reviews on these SDM interventions and on their reported use or outcomes are lacking. This limits the adoption of SDM in clinical practice and hampers further research and development on the subject. Our aim is to provide a comprehensive and up-to-date overview of these SDM interventions by means of a scoping review of the literature. Scoping reviews can provide a broad overview of a topic, identify gaps in the research knowledge base and report on the types of evidence that address and inform practices. This paper presents our study protocol. METHODS AND ANALYSIS: The proposed scoping review will be performed in accordance with the Joanna Briggs Institute’s (JBI) methodology for scoping reviews. It will cover both qualitative and quantitative scientific literature, as well as the grey literature on SDM interventions for treatment modality decisions in AKD. Only literature written in English will be considered for inclusion. Two independent reviewers will participate in an iterative process of screening the literature, paper selection and data extraction. Disagreements between the reviewers will be resolved by discussion until consensus is reached or after consultation with the research team when needed. Results will be reported with descriptive statistics and diagrammatic or tabular displayed information, accompanied by narrative summaries as explained in the JBI guidelines. ETHICS AND DISSEMINATION: Ethical approval for the conduct of this study is not required. We will analyse previously collected data for the proposed scoping review. Our results will be published in a peer-reviewed journal and disseminated through conferences and/or seminars.
format Online
Article
Text
id pubmed-7050317
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70503172020-03-16 Shared decision-making in advanced kidney disease: a scoping review protocol Engels, Noel de Graav, Gretchen van der Nat, Paul van den Dorpel, Marinus Bos, Willem Jan Stiggelbout, Anne M BMJ Open Renal Medicine INTRODUCTION: Patients with advanced kidney disease (AKD) have to make difficult treatment modality decisions as their disease progresses towards end-stage kidney disease. International guidelines in nephrology suggest shared decision-making (SDM) to help patients make timely treatment modality decisions that align with their values and preferences. However, systematic reviews or scoping reviews on these SDM interventions and on their reported use or outcomes are lacking. This limits the adoption of SDM in clinical practice and hampers further research and development on the subject. Our aim is to provide a comprehensive and up-to-date overview of these SDM interventions by means of a scoping review of the literature. Scoping reviews can provide a broad overview of a topic, identify gaps in the research knowledge base and report on the types of evidence that address and inform practices. This paper presents our study protocol. METHODS AND ANALYSIS: The proposed scoping review will be performed in accordance with the Joanna Briggs Institute’s (JBI) methodology for scoping reviews. It will cover both qualitative and quantitative scientific literature, as well as the grey literature on SDM interventions for treatment modality decisions in AKD. Only literature written in English will be considered for inclusion. Two independent reviewers will participate in an iterative process of screening the literature, paper selection and data extraction. Disagreements between the reviewers will be resolved by discussion until consensus is reached or after consultation with the research team when needed. Results will be reported with descriptive statistics and diagrammatic or tabular displayed information, accompanied by narrative summaries as explained in the JBI guidelines. ETHICS AND DISSEMINATION: Ethical approval for the conduct of this study is not required. We will analyse previously collected data for the proposed scoping review. Our results will be published in a peer-reviewed journal and disseminated through conferences and/or seminars. BMJ Publishing Group 2020-02-27 /pmc/articles/PMC7050317/ /pubmed/32111615 http://dx.doi.org/10.1136/bmjopen-2019-034142 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Renal Medicine
Engels, Noel
de Graav, Gretchen
van der Nat, Paul
van den Dorpel, Marinus
Bos, Willem Jan
Stiggelbout, Anne M
Shared decision-making in advanced kidney disease: a scoping review protocol
title Shared decision-making in advanced kidney disease: a scoping review protocol
title_full Shared decision-making in advanced kidney disease: a scoping review protocol
title_fullStr Shared decision-making in advanced kidney disease: a scoping review protocol
title_full_unstemmed Shared decision-making in advanced kidney disease: a scoping review protocol
title_short Shared decision-making in advanced kidney disease: a scoping review protocol
title_sort shared decision-making in advanced kidney disease: a scoping review protocol
topic Renal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050317/
https://www.ncbi.nlm.nih.gov/pubmed/32111615
http://dx.doi.org/10.1136/bmjopen-2019-034142
work_keys_str_mv AT engelsnoel shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol
AT degraavgretchen shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol
AT vandernatpaul shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol
AT vandendorpelmarinus shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol
AT boswillemjan shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol
AT stiggelboutannem shareddecisionmakinginadvancedkidneydiseaseascopingreviewprotocol